Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
1.515
-0.125 (-7.62%)
Aug 20, 2026, 4:00 PM EDT - Market closed
Neumora Therapeutics Market Cap
Neumora Therapeutics has a market cap or net worth of $284.66 million as of August 20, 2026. Its market cap has increased by 9.18% in one year.
Market Cap
284.66M
Enterprise Value
221.08M
1-Year Change
9.18%
Ranking
Category
Stock Price
$1.52
ChartMarket Cap Chart
Since the IPO on September 15, 2023, Neumora Therapeutics's market cap has decreased from $2.58B to $284.66M, a decrease of -88.98%. That is a compound annual growth rate of -52.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 284.66M | -6.42% |
| Dec 31, 2025 | 304.19M | -82.24% |
| Dec 31, 2024 | 1.71B | -34.22% |
| Dec 29, 2023 | 2.60B | 0.79% |
| Sep 15, 2023 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vogenx | 322.33M |
| Fate Therapeutics | 317.52M |
| Cartesian Therapeutics | 317.38M |
| YD Bio | 314.33M |
| Anavex Life Sciences | 314.16M |
| ProQR Therapeutics | 313.29M |
| InflaRx | 312.42M |
| Fulcrum Therapeutics | 298.32M |